Alzheimer's disease - donepezil, rivastigmine and galantamine (replaced by TA111)
Alzheimer's disease (mild to moderate) - donepezil, rivastigmine and galantamine
Summary
This guidance has been updated and replaced by TA111 Alzheimer's disease donepezil, galantamine, rivastigmine (review) and memantine. NICE has recommended that the three drugs donepezil, rivastigmine and galantamine should be made available in the NHS as one part of the management of some people wi ...
Guidance documents
Implementing this guidance
We will consult on our review plans for this guidance in December 2003
About this guidance
Technology appraisals TA19
Issued: January 2001